Preventing Dysplasia in Barrett's Esophagus: Are Proton Pump Inhibitors the Answer?

April 2005
American Journal of Gastroenterology;Apr2005, Vol. 100 Issue 4, p978
Academic Journal
No abstract available.


Related Articles

  • Barrett's oesophagus and hepatitis A jabs.  // GP: General Practitioner;11/7/2008, p27 

    The article presents questions and answers related to medicine including hepatitis A vaccination immunity period and the effect of proton pump inhibitors on a patient with Barrett's esophagus.

  • Proton pump inhibitors reduce the incidence of dysplasia in Barrett's esophagus. Aguirre, Thomas; El-Serag, Hashem; Davis, Stephanie; Bhattacharyya, Achyut; Sampliner, Richard // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS23 

    An abstract of the article "Proton Pump Inhibitors Reduce the Incidence of Dysplasia in Barrett's Esophagus," by Thomas Aguirre, Hashem El-Serag, Stephanie Davis, Achyut Bhattacharyya and Richard Sampliner is presented.

  • Regression of Barrett esophagus using high dose proton pump inhibitor. Barrett, Kurt A // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS1 

    An abstract of the article " Regression of Barrett Esophagus Using High Dose Proton Pump Inhibitor," by Kurt A. Barrett is presented.

  • Barrett's Esophagus--What Should I Know About It?  // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2120 

    Provides information on Barrett's esophagus. Disadvantage of too much stomach acid; Association of gastroesophageal reflux disease with Barrett's esophagus; Use of proton pump inhibitors for treating Barrett's esophagus.

  • BARRETT'S ESOPHAGUS: ACID SUPPRESSION, BUT NO REGRESSION. Bozymski, Eugene M.; Shaheen, Nicholas J. // American Journal of Gastroenterology;Apr1997, Vol. 92 Issue 4, p556 

    Discusses the results of a study on the treatment of patients with Barrett's esophagus with a proton pump inhibitor. Number of patients used in the study; Explanation on the efforts to understand the pathogenic and sustaining mechanism of Barrett's esophagus; Difficulty of quantifying changes...

  • Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort. Brown, Craig; Lapin, Brittany; Wang, Chi; Goldstein, Jay; Linn, John; Denham, Woody; Haggerty, Stephen; Talamonti, Mark; Howington, John; Carbray, Joann; Ujiki, Michael; Brown, Craig S; Goldstein, Jay L; Linn, John G; Haggerty, Stephen P; Talamonti, Mark S; Howington, John A; Ujiki, Michael B // Surgical Endoscopy;Dec2015, Vol. 29 Issue 12, p3528 

    Background: It is unknown whether acid/reflux control prevents progression in Barrett's esophagus. In this study, we investigate whether medical or surgical control of reflux is associated with a decreased risk of progression to dysplasia/esophageal adenocarcinoma.Methods:...

  • Common Questions About Barrett Esophagus. ZIMMERMAN, THOMAS G. // American Family Physician;1/15/2014, Vol. 89 Issue 2, p92 

    Barrett esophagus is a precancerous metaplasia of the esophagus that is more common in patients with chronic reflux symptoms, although it also occurs in patients without symptomatic reflux. Other risk factors include smoking, male sex, obesity, white race, hiatal hernia, and increasing age...

  • Endoscopic Therapy of Barrett's Esophagus and Esophageal Adenocarcinoma. Tantau, Marcel; Mosteanu, Ofelia; Pop, Teodora; Tantau, Alina; Mester, Gabriela // Journal of Gastrointestinal & Liver Diseases;Jun2010, Vol. 19 Issue 2, p213 

    The normal squamous esophageal epithelium reacts as a chronic inflammation to the severe gastro-esophageal reflux. Esophagitis will progress to Barrett metaplasia in 10% of patients who would be of minor clinical interest if it then did not advance to low, high grade dysplasia and invasive...

  • Barrett's guidelines update includes screening, surveillance, management.  // Geriatrics;May2008, Vol. 63 Issue 5, p21 

    The article reports on the new guidelines for diagnosing and treating Barrett's esophagus published by the American College for Gastroenterology. According to the guidelines, patients with low-grade dysplasia need follow-up endoscopy within 6 months and those with high-grade dysplasia within...

  • CLINICAL OUTCOME OF PATIENTS WITH LOW GRADE DYSPLASIA IN BARRETT'S OESOPHAGUS. Gupta, S.; Amaout, A.; Theodossi, A.; Mendall, M. A. // Gut;Apr2004 Supplement 3, Vol. 53, pA59 

    Barrett's esophagus (BO) is a premalignant condition with histopathological evidence of dysplasia being the best marker of increased cancer risk. Of the 273 patients with histology confirmed BO, there were 45 patients with low grade dysplasia (LGD) and 2 patients with high grade dysplasia...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics